New York Life Investment Management’s Prothena Corp PRTA Stock Holding History

New York Life Investment Management’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,407	Closed	-$357K	–	1207
2024 Q1	$357K	Buy	+14,407	New	+$429K	﹤0.01%	1255
2015 Q4	–	Sell	-6,029	Closed	-$273K	–	179
2015 Q3	$273K	Buy	6,029 +291	+5%	+$16.9K	0.03%	182
2015 Q2	$302K	Buy	5,738 +238	+4%	+$9.39K	0.03%	171
2015 Q1	$210K	Hold	5,500	–	–	0.02%	190
2014 Q4	$114K	Buy	5,500 +73	+1%	+$1.52K	0.01%	237
2014 Q3	$120K	Buy	+5,427	New	+$115K	0.02%	175

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York Life Investment Management's PRTA Position: Q2 2024 in Review

New York Life Investment Management sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 14,407 shares — an estimated $357K sold.

New York Life Investment Management first reported a position in PRTA in Q3 2014 and held it in 6 quarters. The position peaked at $357K in Q1 2024. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

New York Life Investment Management reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
New York Life Investment Management sold 14,407 Prothena Corp shares in Q2 2024, an estimated $357K.
New York Life Investment Management first reported a position in Prothena Corp in Q3 2014 and held it in 6 quarters.
New York Life Investment Management's Prothena Corp position peaked at $357K in Q1 2024.
160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.